News
-
GlaxoSmithKline and Innoviva have announced the initiation of a Phase 3 study of a fluticasone furoate/umeclidinium/vilanterol DPI compared to Relvar/Breo Ellipta for the treatment of asthma. GSK recently filed regulatory submissions for the FF/UMEC/VI DPI… Read more . . .
-
While acknowledging the 60th anniversary of the metered dose inhaler, the 27th annual Drug Delivery to the Lungs meeting devoted much of its program to looking forward beyond conventional devices, formulations, and targets. More than… Read more . . .
-
Lonza Group will acquire capsule manufacturer and CDMO Capsugel from KKR for $5.5 billion, the company has announced. The deal has been approved by the boards of both companies and is expected to close by… Read more . . .
-
Cephalgia, a startup spun out of the University of Chicago, will receive $250,000 from the university’s Innovation Fund for development of intranasal IGF-1 for the treatment of migraine, according to the fund. The company was… Read more . . .
-
Propeller Health has announced that its inhaler monitoring platform will integrate with mobile and clinical spirometers from Medical International Research (MIR). According to Propeller, its platform “is the only commercially marketed respiratory digital health solution… Read more . . .
-
Adherium has announced that its Smartinhaler has been selected for use in the myAirCoach project, which will study the effectiveness of mHealth systems for asthma control. The program, which includes participation by Imperial College London,… Read more . . .
-
Following the signing of an international phase-down agreement regarding fluorinated gases in October 2016, pMDI propellent supplier Mexichem stated that it “does not believe the recent Kigali Amendment to the Montreal Protocol, nor regulatory controls… Read more . . .
-
H&T Presspart and Cohero Health have officially launched the eMDI connected metered dose inhaler (eMDI), which integrates with Cohero Health’s BreatheSmart inhaler tracking and lung function measurement platform. The two companies initially announced the eMDI… Read more . . .
-
OINDP development specialist Nanopharm has appointed Arron Danson as Head of Device Development, the company said. Danson has extensive experience in the development of pulmonary and nasal delivery devices, having worked at companies such as… Read more . . .
-
GlaxoSmithKline and Innoviva have announced that GSK has filed an MAA with the European Medicines Agency for its fluticasone furoate/umeclidinium/vilanterol DPI for the treatment of COPD. In November 2016, GSK submitted an NDA for the… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.